Home/Filings/4/0001809519-25-000016
4//SEC Filing

Wagner Scott 4

Accession 0001809519-25-000016

CIK 0001809519other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 5:15 PM ET

Size

11.0 KB

Accession

0001809519-25-000016

Insider Transaction Report

Form 4
Period: 2025-01-21
Wagner Scott
Director
Transactions
  • Award

    Deferred Stock Unit

    2025-01-21+94,18294,182 total
    Class A Common Stock (94,182 underlying)
  • Award

    Class A Common Stock

    2025-01-21+9,524298,633 total
  • Award

    Class A Common Stock

    2025-01-21+19,217317,850 total
Holdings
  • Class A Common Stock

    (indirect: By Trust)
    182,900
Footnotes (5)
  • [F1]Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
  • [F2]Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) June 6, 2025 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
  • [F3]Shares held directly by the Wagner Family Trust (the "Trust"). The Reporting Person and his spouse serve as trustees of the Trust, and the Reporting Person, his spouse and other members of his immediate family are the sole beneficiaries of the Trust.
  • [F4]Each deferred stock unit represents a contingent right to receive one share of Class A common stock.
  • [F5]The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on January 21, 2026, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

Issuer

GoodRx Holdings, Inc.

CIK 0001809519

Entity typeother

Related Parties

1
  • filerCIK 0001342655

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:15 PM ET
Size
11.0 KB